Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiotherapy Induced Nausea and Vomiting”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Large-scale testing (Phase 3)Study completedNCT05564286
What this trial is testing

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Who this might be right for
Cervical CancerNasopharyngeal CancerChemotherapy-induced Nausea and Vomiting+2 more
Shantou University Medical College 116
Large-scale testing (Phase 3)Study completedNCT00971399
What this trial is testing

Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting

Who this might be right for
Radiotherapy Induced Nausea and Vomiting
Seoul National University Hospital 172
Post-approval studies (Phase 4)Looking for participantsNCT07217600
What this trial is testing

Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy

Who this might be right for
Radiotherapy-induced Nausea and Vomiting (RINV)Pediatric Cancer
Chongqing University Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01534637
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerNauseaVomiting+3 more
Wake Forest University Health Sciences 22
Testing effectiveness (Phase 2)Ended earlyNCT00903396
What this trial is testing

Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Alliance for Clinical Trials in Oncology 7
Testing effectiveness (Phase 2)Ended earlyNCT01183481
What this trial is testing

Aprepitant and Granisetron for the Prophylaxis of Radiation Induced Nausea and Vomiting - A Pilot Study

Who this might be right for
NauseaVomiting
Sunnybrook Health Sciences Centre 19
Not applicableStudy completedNCT00621660
What this trial is testing

Acupuncture Versus Sham for Radiotherapy-Induced Emesis

Who this might be right for
NauseaVomiting
University Hospital, Linkoeping 237
Testing effectiveness (Phase 2)Study completedNCT03572829
What this trial is testing

Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

Who this might be right for
VomitingNausea Post ChemotherapyHead Neck Cancer
Chinese Academy of Medical Sciences 44
Testing effectiveness (Phase 2)Study completedNCT02388750
What this trial is testing

Prospective Study of Palonosetron in Radiation Induced Nausea and Vomiting (RINV)

Who this might be right for
NauseaVomiting
Dr. Edward Chow 96
Not applicableUnknownNCT06341985
What this trial is testing

DOsimetry and Radiation Induced NAusea in Head and Neck Cancers

Who this might be right for
Head and Neck Cancer
European Institute of Oncology 180
Testing effectiveness (Phase 2)Study completedNCT01700140
What this trial is testing

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Who this might be right for
Radiotherapy-induced Nausea and Vomiting (RINV)
SymBio Pharmaceuticals 189
Testing effectiveness (Phase 2)Ended earlyNCT00895245
What this trial is testing

Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Nausea and VomitingStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the Larynx+8 more
University of Washington 6
Not applicableNot Yet RecruitingNCT06869005
What this trial is testing

Predict CHimio-or Radiation-induced NAusea and Vomiting in Children/adolescents Treated for Cancer

Who this might be right for
Childhood CancerNausea with Vomiting Chemotherapy-Induced
Rennes University Hospital 150
Testing effectiveness (Phase 2)UnknownNCT05202275
What this trial is testing

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

Who this might be right for
NauseaVomitingHead and Neck Squamous Cell Carcinoma+1 more
Chinese Academy of Medical Sciences 43
Not applicableUnknownNCT02016807
What this trial is testing

ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial

Who this might be right for
Oral MucositisNauseaVomiting+1 more
Ashley Downs Bioscience 180
Testing effectiveness (Phase 2)Study completedNCT02006056
What this trial is testing

Ondissolve in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting

Who this might be right for
NauseaVomiting
Sunnybrook Health Sciences Centre 30
Large-scale testing (Phase 3)UnknownNCT03668639
What this trial is testing

Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin

Who this might be right for
Chemotherapy-induced Nausea and VomitingAdverse EventCervical Cancer
Christina Ruhlmann 80
Testing effectiveness (Phase 2)Study completedNCT02991456
What this trial is testing

Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide

Who this might be right for
Chemo-radiation Induced Nausea and Vomiting
Duke University 48
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211